Cytarabine Injection

Cytarabine Injection

Categories : Oncology

Product Packaging : Single Vial

Product Composition : 100mg/ml, 500mg/5ml, 1000mg/10ml

Cytarabine Injection is a potent antimetabolite anticancer (chemotherapy) injectable formulation widely used in the treatment of hematological malignancies. Cytarabine works by inhibiting DNA synthesis, thereby preventing the proliferation of rapidly dividing cancer cells, particularly in leukemia.

This oncology injectable is a cornerstone in chemotherapy protocols for blood cancers and is commonly used in induction and consolidation therapy. The injectable route ensures controlled delivery, high efficacy, and rapid therapeutic action in critical clinical settings.

Manufactured under stringent sterile and oncology-grade conditions, Cytarabine Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent quality. As a trusted Cytarabine Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Send Message

Cytarabine Injection is a potent antimetabolite anticancer (chemotherapy) injectable formulation widely used in the treatment of hematological malignancies. Cytarabine works by inhibiting DNA synthesis, thereby preventing the proliferation of rapidly dividing cancer cells, particularly in leukemia.

This oncology injectable is a cornerstone in chemotherapy protocols for blood cancers and is commonly used in induction and consolidation therapy. The injectable route ensures controlled delivery, high efficacy, and rapid therapeutic action in critical clinical settings.

Manufactured under stringent sterile and oncology-grade conditions, Cytarabine Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent quality. As a trusted Cytarabine Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Cytarabine Injection is commonly used in the treatment of:

  • Acute Myeloid Leukemia (AML)
  • Acute Lymphocytic Leukemia (ALL)
  • Chronic Myelogenous Leukemia (CML) – blast crisis phase
  • Non-Hodgkin’s Lymphoma (in specific regimens)
  • Other hematological malignancies as per clinical protocols

This chemotherapy injection is administered under strict medical supervision in oncology and hematology settings

Injectable dosage form offers critical advantages in oncology care:

  • Precise dosing and controlled administration
  • Ensures high bioavailability and rapid action
  • Suitable for hospital and specialized cancer treatment centers
  • Allows flexibility in chemotherapy protocols (IV, intrathecal use as applicable)
  • Supports large-scale oncology contract manufacturing and export supply

whatsapp-app